Stock listing

NASDAQ:RAPT RAPT Therapeutics Inc Stock

Follow RAPT Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RAPT

$58.01 USD

Close on Mar 2, 2026 · No longer trades

Jun 16, 2025 to last close +603.9% · daily closes, Jun 16, 2025 – Mar 2, 2026
Lowest – highest close
$7.33 – $58.01 USDSince Jun 16, 2025 · lowest Jul 1, 2025 · highest Mar 2, 2026

Delisted NASDAQ:RAPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RAPT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

RAPT Therapeutics Inc on 6ix

Decks
13 decks · latest Jan 14, 2026

Decks

DeckKindSlidesDate
Investor Presentation (January 2026)Investor deck28 slidesJan 14, 2026
Corporate Update (October 2025)Corporate update18 slidesOct 20, 2025
Investor Presentation (July 2025)Investor deck25 slidesJul 8, 2025
Investor Presentation (June 2025)Investor deck25 slidesJun 9, 2025
Investor Presentation (January 2025)Investor deck25 slidesJan 13, 2025
Investor Presentation (December 2024)Investor deck21 slidesDec 23, 2024
Investor Presentation (March 2023)Investor deck28 slidesMar 14, 2023
Investor Presentation (January 2023)Investor deck28 slidesJan 9, 2023
Investor Presentation (September 2022)Investor deck29 slidesSep 6, 2022
Investor Presentation (September 2021)Investor deck26 slidesSep 27, 2021
All 13 decks
DeckKindSlidesDate
Technical Presentation (June 2021)Technical15 slidesJun 14, 2021
Technical Presentation (November 2020)Technical29 slidesNov 16, 2020
Investor Presentation (January 2020)Investor deck37 slidesJan 9, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mary Ann Gray
Other companies: BioAtla, Inc. (Director · Since at least Jun 16, 2022); Keros Therapeutics, Inc. (Director · Since at least Jun 1, 2022); Compass Therapeutics, Inc. (President, Gray Strategic Advisors, LLC · Since at least Apr 26, 2022); Palisade Bio, Inc. (Director · Jun 11, 2023 – Nov 21, 2023 · Past)
Director · Since at least Mar 31, 2022
Peter Svennilson
Other companies: Revolution Medicines, Inc. (Director · Jun 17, 2020 – Apr 26, 2021 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Gritstone bio, Inc. (Director · Jun 19, 2019 – Jun 19, 2019 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 8, 2020 · Past)
Director · Jun 18, 2020 – May 28, 2021 · Past
William Rieflin
Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past)
Director · Oct 30, 2019 – May 22, 2024 · Past
Ashley L Dombkowski
Other companies: Hudson Executive Investment Corp III (Director · Feb 23, 2021 – Feb 23, 2021 · Past)
Director · Since at least Jun 21, 2025
Dirk G Brockstedt
Other companies: Aduro Biotech Inc (EVP of Research and Dev. · Oct 2, 2017 – Dec 29, 2017 · Past)
CHIEF SCIENTIFIC OFFICER · Since at least Oct 30, 2019
Michael F Giordano
Other companies: Epizyme Inc (Director · Jun 11, 2021 – Aug 12, 2022 · Past)
Director · Since at least May 28, 2021
Eric J HallInterim CFO · Oct 30, 2019 – Oct 30, 2019 · Past
Rodney KB YoungCHIEF FINANCIAL OFFICER · Since at least May 10, 2022
Wendye RobbinsDirector · Jun 29, 2020 – Mar 31, 2025 · Past
William HoCHIEF MEDICAL OFFICER · Since at least Oct 30, 2019

Open People

Log in to ask 6ix AI your own questions about RAPT Therapeutics Inc.